Alexion sinks as PTAB institutes review that could shorten Soliris' exclusivity

Alexion shed nearly $2.6 billion in market cap Friday after an arm of the U.S. Patent and Trademark Office said it will review the validity of three patents covering Soliris based on an inter partes review challenge

Read the full 377 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE